Researchers are arguing over whether ‘disruptive’ or ‘novel’ science is waning – and how to remedy the problem.

An essay by Chinaemerem Uju Onyishi, PhD Early clinical research and the exclusion of women Historically, it was thought there was no major difference between male and female bodies aside from size an...

Gurung et al. show that young subcutaneous adipocytes provide lipids and phosphatidylcholine to melanoma cells, which activates PI3K-AKT, OXPHOS, and oxidative stress. High OXPHOS reduces metastatic b...

Computer scientists and bioinformaticians address four key questions to help rookie coders to make the right choice.

A trawl of job views and application data suggests jobseekers are looking abroad as the Trump administration’s cuts to science take hold.

A new study seems to confirm that a single dose of the vaccine used to prevent HPV infection is just as effective as two — and, therefore, also helps to prevent cancer.

“We are navigating political interference, institutional instability, and growing uncertainty across the cancer research enterprise": At AACR, cancer researchers are speaking up.

NCI Director Kimryn Rathmell shared advice for early-career cancer researchers with members of the AACR Associate Member Council.